Republican Administration Maintains Exclusivity Stance in GLP-1 (Tirzepatide) Compounding Dispute

Lilly expanding their cash for vials program does provide an off ramp for many that were paying for compound. It is only about $100-$200 more per month than compound if on a dose <=10mg.

Still super expensive compared to gray but for many this could be an option. With insurance my Zepbound co-pay is just over $200 (for any dose) so $500 without insurance isn't as crazy as it sounds, especially if you don't have access to, or don't want to go gray.
I think they released vials in the US in part to negate any compounding argument for odd dosages. Now if a patient says they can't tolerate 5mg and need 4mg it can happen. Takes the legs off one of the compounders main arguments. Some telehealth anticipated this from the beginning... I know Henry Meds initial dosage schedule didn't align with Lilly's and several telehealth offered unique dosages the moment Tirz came off the shortage list in the fall.
 
Last edited:
Anyone else having trouble keeping their mouth shut? 🤐 I am. I think it was Shakespeare who said something like “Discretion is the greater part of valor”
 
i don't know why a couple more weight loss drugs can't be expedited. so many in these damn trials that will take forever. maybe they can help with that.
I don’t know how something can be better than what’s already here. It seems so amazing to me as is. Unless it’s a competitor of NN or EL, there is no benefit to something else coming out. The smart financial play is to wait until the patent expires.
 
I’m locking this thread the moment it gets even a little bit into partisan politics.

I give it 2 hours but prove me wrong.
We proved you wrong. Although we all know you’ll have to lock the thread at some point, we far exceeded your prediction.
 

Trending content

Forum statistics

Threads
2,428
Messages
43,384
Members
4,352
Latest member
Christy7774
Back
Top